3 completed, 1 unknown. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Onycholysis: new trials by email Literature Review of Onycholysis trials Research Report on Onycholysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Distal Erosions and Nail Psoriasis HR-pQCT High resolution peripheral quantitative CT-scan - Psoriatic Arthritis | Unknown | Hospices Civils de Lyon | 104 | 2013-11-01 | 2016-06-28 | |
| Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 604 | 2011-02-01 | 2019-04-03 |
| Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 594 | 2010-12-01 | 2019-02-22 |
| Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis Placebo, Terbinafine Hydrochloride, Terbinafine - Onychomycosis/Onycholysis and Tinea Pedis | Phase 1 | Completed | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 56 | 2005-02-01 | 2008-06-05 |
Onychomycosis (3) · Foot Dermatoses (2) · Keratoderma, Palmoplantar, Epidermolytic (2) · Nails, Malformed (2) · Twenty-Nail Dystrophy (2) · Yellow Nail Syndrome (2) · Arthritis, Psoriatic (1) · Tinea Pedis (1)
Nail Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Bacterial Infections and Mycoses (3) · Dermatomycoses (3) · Foot Diseases (3) · Infections (3) · Mycoses (3) · Pathological Conditions, Signs and Symptoms (3) · Skin Diseases, Infectious (3) · Tinea (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Keratoderma, Palmoplantar (2) · Keratoderma, Palmoplantar, Diffuse (2)
Solutions (2) · Tablets (1) · Terbinafine (1)
Pfizer (2) · Hospices Civils de Lyon (1) · NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) (1)
United States (3) · Canada (1) · France (1)
Cyrille Confavreux, MD PHD (1) · Ming Q Lu, MD., Ph.D. (1)